Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
The American Journal of the Medical Sciences|March 5, 2011
Epidemiology of spondyloarthritis in ArgentinaEmilio Buschiazzo, Jose A Maldonado-Cocco, Pablo Arturi, et al.
RMD Open|April 26, 2016
Reductions in disease activity in the AMPLE trial: clinical response by baseline disease durationMichael Schiff, Michael E Weinblatt, Robert Valente, et al.
Clinical Rheumatology|March 22, 2013
Adherence to treatment in patients with ankylosing spondylitisPablo Arturi, Emilce Edith Schneeberger, Fernando Sommerfleck, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 4, 2008
Prevalence and clinical significance of eosinophilia in patients with rheumatoid arthritis in ArgentinaFlavia Chiardola, Emilce Edith Schneeberger, Gustavo Citera, et al.
Clinical Rheumatology|October 29, 2025
Long-term persistence of biological agents in the treatment of patients with rheumatoid arthritis: a systematic literature review and meta-analysisEmilce Edith Schneeberger, María Laura Acosta Felquer, Gustavo Citera, et al.
The Journal of Rheumatology|July 15, 2022
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled TrialEmilce E Schneeberger, Gustavo Citera, Dario Ponce de Leon, et al.
Open Access Rheumatology : Research and Reviews|June 2, 2012
Prevalence of periprosthetic osteolysis after total hip replacement in patients with rheumatic diseasesRodolfo Perez Alamino, Carolina Casellini, Andrea Baňos, et al.
Arthritis and Rheumatism|November 22, 2012
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized studyMichael E Weinblatt, Michael Schiff, Robert Valente, et al.
Annals of the Rheumatic Diseases|August 22, 2013
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trialMichael Schiff, Michael E Weinblatt, Robert Valente, et al.
Rheumatology and Therapy|September 20, 2022
Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled TrialsMartin Bergman, Maya H Buch, Yoshiya Tanaka, et al.
Pageof 9